Prostate Adenocarcinoma
Showing 51 - 75 of 187
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Laboratory Biomarker Analysis, Olaparib,
Active, not recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
- Laboratory Biomarker Analysis
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 19, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Moscow (consequently performed 4 biopsy methods (TRUS-guided biopsy,
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
- consequently performed 4 biopsy methods (TRUS-guided biopsy, cognitive, fusion and transperineal template mapping biopsy)
-
Moscow, Russian FederationInstitute for Urology and Reproductive Health, Sechenov Universi
Oct 18, 2022
Metastatic Prostate Cancer, Prostate Adenocarcinoma Trial in Worldwide (Cabozantinib, Atezolizumab, Abiraterone Acetate)
Recruiting
- Metastatic Prostate Cancer
- Prostate Adenocarcinoma
- Cabozantinib
- +4 more
-
Tucson, Arizona
- +259 more
Oct 19, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022
Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,
Recruiting
- Prostate Adenocarcinoma
- +2 more
- Atezolizumab
- +2 more
-
San Francisco, California
- +1 more
Oct 8, 2022
Prostate Adenocarcinoma, Prostate Cancer Trial in San Francisco (Hyperpolarized Carbon C 13 Pyruvate, Magnetic Resonance
Recruiting
- Prostate Adenocarcinoma
- Prostate Cancer
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 3, 2022
Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States
Recruiting
- Prostate Adenocarcinoma
- +6 more
- Gonadotrophin Releasing Hormone
- +2 more
-
Gilbert, Arizona
- +86 more
Sep 27, 2022
Prostate Adenocarcinoma Trial in Duarte (drug, radiation, other)
Recruiting
- Prostate Adenocarcinoma
- Leuprolide Acetate
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle
Active, not recruiting
- Castration-Sensitive Prostate Carcinoma
- +7 more
- Antiandrogen Therapy
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Metastatic Prostate Carcinoma, Prostate Adenocarcinoma, Prostate Carcinoma Metastatic in the Bone Trial in Houston (Abiraterone
Active, not recruiting
- Metastatic Prostate Carcinoma
- +5 more
- Abiraterone Acetate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 26, 2022
Prostate-Specific Membrane Antigen PET Scans in People Prostate
Recruiting
- Prostate Cancer
- +4 more
- 18F-DCFPyL-iPSMA
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 29, 2022
Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)
Recruiting
- Castration-Resistant Prostate Carcinoma
- Prostate Adenocarcinoma
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 23, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,
Not yet recruiting
- Oligometastatic Prostate Carcinoma
- +3 more
- Lutetium Lu-177 PNT2002
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022
Prostate Adenocarcinoma Trial in Tucson (F-18 fluciclovine-PET/CT scan)
Completed
- Prostate Adenocarcinoma
- F-18 fluciclovine-PET/CT scan
-
Tucson, ArizonaUniversity of Arizona
Aug 12, 2022
Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Decatur, Effingham,
Recruiting
- Oligometastatic Prostate Carcinoma
- +2 more
- Placebo Administration
- +3 more
-
Decatur, Illinois
- +2 more
Aug 11, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Canada, United States (Radical Prostatectomy, TULSA Procedure)
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Radical Prostatectomy
- TULSA Procedure
-
Tarzana, California
- +7 more
Aug 10, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Prostate Adenocarcinoma, Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8 Trial in San Francisco (Angiogram,
Recruiting
- Prostate Adenocarcinoma
- +9 more
- Angiogram
- +3 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 5, 2022
Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Houston (Fluorine F
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +2 more
- Fluorine F 18 rhPSMA-7.3
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Aurora, Denver (Ga-PSMA-11)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Aurora, Colorado
- +1 more
Jul 28, 2022
Prostate Adenocarcinoma Trial in Haifa (Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT))
Recruiting
- Prostate Adenocarcinoma
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Haifa, Israel
- +1 more
Jul 4, 2022
Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,
Recruiting
- Localized Prostate Carcinoma
- +8 more
- Apalutamide
- Quality-of-Life Assessment
-
Tucson, Arizona
- +4 more
Jun 28, 2022
Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United
Active, not recruiting
- Prostate Adenocarcinoma
- +3 more
- Hypofractionated radiation therapy
- +2 more
-
Birmingham, Alabama
- +240 more
Jun 6, 2022
Prostate Adenocarcinoma Trial in United States (Illuminare-1, Karl Storz D-Light C photodynamic diagnostic (PDD))
Recruiting
- Prostate Adenocarcinoma
- Illuminare-1
- Karl Storz D-Light C photodynamic diagnostic (PDD)
-
Basking Ridge, New Jersey
- +5 more
Jun 20, 2022